Comprehensive Reference — Updated 2025

Neurodiversity
Unfiltered

Every definition, every data point, every controversy — autism, ADHD, disability, neurodivergence. Dictionaries, medical manuals, research, politics, and medications in one authoritative reference.

1 in 31
U.S. children with ASD
CDC ADDM, 2025 (age 8 cohort)
75M+
People with autism worldwide
WHO estimate, 1% global prevalence
4:1
Male-to-female diagnosis ratio
CDC; some research suggests 3:1
~1in 9
U.S. children diagnosed with ADHD
CDC NSCH, 2023
312%
Increase in ASD diagnosis since 2000
1 in 150 (2000) → 1 in 31 (2025)
Section 01 — Lexical Reference

The Definitions

How the world's major dictionaries, diagnostic manuals, the WHO, APA, and Wikipedia define autism, neurodiversity, and related conditions. Sources are color-coded.

Neurodiversity

/ ˌnjʊərəʊdaɪˈvɜːsɪti /

noun · coined c. 1998 · sociology / disability studies / advocacy

Merriam-Webster2024

Individual variation in the functioning of the brain and nervous system, especially when viewed as being normal and natural rather than a disorder; the inclusion of people exhibiting such variation.

Cambridge Dictionary2024

The fact that people's brains work in different ways, and that this is a normal thing, not something to be corrected or seen as less valuable than a more typical brain.

Collins English Dictionary2024

The range of differences in individual brain function and behavioural traits, regarded as part of normal variation in the human genome. The term was coined by sociologist Judy Singer in the late 1990s, though this attribution has since been contested.

Wikipedia2024

The concept that variations in neurological development are normal and part of natural human biodiversity. The term emerged from autistic-led online communities in the 1990s. It encompasses autism spectrum disorder, ADHD, dyslexia, dyspraxia, dyscalculia, Tourette syndrome, and related conditions. As both a descriptive term and a social movement, it argues that cognitive differences should be accommodated rather than "cured."

Dictionary.com / Oxford Languages2024

The range of differences in individual brain function and behavioural traits, and the idea that variation in human cognition is something to be recognized and respected rather than pathologized.

Autism / ASD

/ ˈɔːtɪzəm / ˌeɪ.ɛs.ˈdiː /

noun · from Greek autos (self) · neurodevelopmental · first described by Leo Kanner, 1943

Merriam-Webster2024

A developmental disorder that is characterized by persistent deficits in social interaction and communication and by restricted and repetitive patterns of behavior, interests, or activities, that is usually evident from early childhood, and that ranges from mild to severe in severity.

Oxford English Dictionary2024

A developmental condition (more fully autism spectrum condition or disorder) of variable severity typically involving difficulties in social interaction and communication, restricted and repetitive patterns of behavior and interests, and sensory sensitivities. Awareness of the condition has grown significantly since the late 20th century.

Cambridge Dictionary2024

A condition in which someone has difficulties with social communication and interaction, and often has restricted, repetitive patterns of behavior, interests, or activities, and is often thought of not as a disease to be cured but as a different way of experiencing the world.

DSM-5-TR (APA)2022

A neurodevelopmental disorder defined by persistent deficits in social communication and social interaction across multiple contexts (Criterion A), and restricted, repetitive patterns of behavior, interests, or activities (Criterion B). Symptoms must be present in early childhood (though they may not become apparent until social demands exceed capacity). Severity is specified by support level required (Level 1–3) and the presence or absence of intellectual impairment, language impairment, and associated medical/genetic conditions.

WHO / ICD-112022

Autism Spectrum Disorder (ICD-11: 6A02) is characterized by persistent deficits in the ability to initiate and sustain social communication and interaction, and a range of restricted, repetitive, and inflexible patterns of behaviour and interests. The onset occurs during the developmental period, typically in early childhood, but symptoms may not fully manifest until social demands exceed limited capacities. The condition exists on a continuum from mild to severe.

APA Dictionary of Psychology2023

A neurodevelopmental disorder whose essential features are persistent impairment in reciprocal social communication and social interaction, and restricted, repetitive patterns of behavior, interests, or activities. These core features are present from early childhood and limit or impair everyday functioning. The disorder is characterized by considerable variation in symptom expression, severity, and co-occurring conditions.

WikipediaRetrieved 2025

Autism, formally known as autism spectrum disorder (ASD), is a neurodevelopmental disorder characterized by deficits in social communication and social interaction, and by restricted and repetitive patterns of behavior and interests. These characteristics are thought to arise from atypical development of the brain and nervous system. The condition affects an estimated 1–2% of the global population. In a 2025 CDC report based on 2022 data, 1 in 31 children in the United States was identified with ASD.

ADHD

/ ˌeɪ.diː.eɪtʃ.ˈdiː /

noun · attention-deficit/hyperactivity disorder · DSM recognizes since 1980 (as ADD)

Merriam-Webster2024

A developmental disorder that is marked by persistent and impairing symptoms of inattention, hyperactivity, and impulsivity or a combination of these symptoms. The disorder typically begins in childhood and may persist into adulthood.

Cambridge Dictionary2024

Attention deficit hyperactivity disorder: a medical condition in which someone, especially a child, is often in a state of activity or excitement and unable to direct their attention towards what they are doing for very long.

DSM-5-TR (APA)2022

A persistent pattern of inattention and/or hyperactivity-impulsivity that interferes with functioning or development. Inattention manifests as wandering off task, lack of persistence, difficulty sustaining focus, and disorganization. Hyperactivity-impulsivity includes excessive motor activity when it is not appropriate and fidgetiness, talkativeness, or restlessness, as well as impulsive action, difficulty waiting, and intrusiveness on others. Three presentations: predominantly inattentive, predominantly hyperactive-impulsive, and combined.

WHO / ICD-112022

Attention deficit hyperactivity disorder (ICD-11: 6A05) is characterised by a persistent pattern (at least 6 months) of inattention and/or hyperactivity-impulsivity that has a direct negative impact on academic, occupational, or social functioning. Signs of inattention and hyperactivity-impulsivity should be evident across multiple settings and inconsistent with the expected developmental level.

WikipediaRetrieved 2025

Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by inattention, or excessive activity and impulsivity, which are otherwise not appropriate for a person's age. Some individuals with ADHD also display difficulty regulating emotions or problems with executive function. Worldwide, ADHD affects approximately 5–10% of children and 2–5% of adults. It is one of the most common childhood-onset neurodevelopmental conditions and is highly heritable.

Special Needs

/ ˈspɛʃ.əl niːdz /

noun phrase · education / law / social policy

Terminology note: "Special needs" is increasingly viewed as outdated or stigmatizing by disabled people's advocacy groups in many contexts. Alternatives such as "disabled," "person with a disability," "support needs," or condition-specific language are often preferred. Usage varies significantly by country, context, and individual preference.
Merriam-Webster2024

Any of various difficulties (such as a physical, emotional, behavioral, or learning disability or impairment) that causes an individual to require additional or specialized services or accommodations (as in education or recreation).

Cambridge Dictionary2024

The particular requirements of people with mental or physical disabilities: children with special needs; special-needs education. Often qualified as "educational special needs."

Collins English Dictionary2024

The particular educational requirements of children with learning difficulties, physical disabilities, or emotional problems. Used also in broader contexts to refer to requirements for people of all ages with various disabilities or impairments.

UNESCO / Salamanca Statement1994 / updated

Refers to all children and youth whose needs arise from disabilities or learning difficulties. Schools must accommodate all children regardless of their physical, intellectual, social, emotional, linguistic or other conditions. This includes disabled and gifted children, street and working children, children from remote or nomadic populations, and children from other disadvantaged or marginalized areas or groups.

Disability

/ ˌdɪs.əˈbɪl.ɪ.ti /

noun · legal / medical / social

Merriam-Webster2024

A physical, mental, cognitive, or developmental condition that impairs, interferes with, or limits a person's ability to engage in certain tasks or actions or participate in typical daily activities and interactions.

WHO / ICF2021

An umbrella term for impairments, activity limitations, and participation restrictions. Disability is not simply a health problem. It is a complex phenomenon, reflecting the interaction between features of a person's body and features of the society in which they live. Over 1 billion people (15% of the world's population) experience some form of disability.

UN CRPD2006

Persons with disabilities include those who have long-term physical, mental, intellectual or sensory impairments which in interaction with various barriers may hinder their full and effective participation in society on an equal basis with others (Article 1, CRPD). The CRPD conceptualizes disability within the social model framework.

WikipediaRetrieved 2025

Disability is the experience of any condition that makes it more difficult for a person to do certain activities or have equitable access within a given society. This is the social model of disability. The medical model defines disability in terms of impairment. The biopsychosocial model holds it is a product of both. Prominent theoretical frameworks include the social model (Oliver, 1990), critical disability studies, and crip theory.

Intellectual Disability

/ ɪnˌtelek.tʃuəl dɪsˈæb.ɪl.ɪ.ti /

noun phrase · medicine / psychology · formerly: mental retardation

DSM-5-TR (APA)2022

Intellectual developmental disorder: a disorder with onset during the developmental period that includes both intellectual and adaptive functioning deficits in conceptual, social, and practical domains. Three criteria must be met: deficits in intellectual functions confirmed by standardized testing (typically IQ <70, i.e. ~2 SD below mean); deficits in adaptive functioning that fail to meet developmental and sociocultural standards for personal independence and social responsibility; onset of intellectual and adaptive deficits during the developmental period.

WHO / ICD-112022

Disorders of intellectual development (ICD-11: 6A00) are a group of etiologically diverse conditions originating during the developmental period, characterized by significantly below-average intellectual functioning and adaptive behavior approximately 2 or more standard deviations below the mean. Severity levels: mild (IQ ~50–69), moderate (IQ ~35–49), severe (IQ ~20–34), profound (IQ <20).

WikipediaRetrieved 2025

Intellectual disability (ID), also known as intellectual developmental disorder (IDD), is characterized by significant limitations in intellectual functioning and adaptive behavior, originating before age 18. Down syndrome is the most common identifiable chromosomal cause. Approximately 1–3% of the population is estimated to have an intellectual disability. Around 26.7% of autistic individuals also have intellectual disability, per 2022 CDC data.

Developmental Disability

/ dɪˌvel.əpˈmen.t(ə)l dɪsˈæb.ɪl.ɪ.ti /

noun phrase · law / medicine — broader legal category in U.S. law

Merriam-Webster2024

Any of a diverse group of severe, chronic conditions arising before age 22 from mental or physical impairment (or both) that result in substantial limitations in major life activities including self-care, learning, mobility, self-direction, language, or independent living.

WikipediaRetrieved 2025

Developmental disability is a diverse group of chronic conditions due to mental or physical impairments arising before adulthood. Examples include autism spectrum disorder, intellectual disability, cerebral palsy, Down syndrome, fetal alcohol spectrum disorders, and epilepsy. The U.S. Developmental Disabilities Assistance and Bill of Rights Act (DD Act) defines the term and provides the legal basis for federal funding.

Inclusion / Inclusive Education

/ ɪnˈkluː.ʒən /

noun · education policy / UN convention

Cambridge Dictionary2024

The act or practice of including students with disabilities in the general classroom, with appropriate supports, rather than segregating them into specialist settings.

Oxford Reference — Education2023

The principle and practice of educating pupils with special educational needs alongside mainstream peers, with appropriate support, rather than in segregated provision. Distinguished from mere "integration" (physical presence) by the emphasis on full participation and belonging.

UNESCO / Salamanca Statement1994

Inclusive education is the process of strengthening the capacity of the education system to reach out to all learners. Schools that operate inclusively are the foundation of a compassionate society. Inclusion recognizes that discrimination and exclusion run along a spectrum, and that genuine inclusion means restructuring curriculum, teaching methods, and school culture to welcome all.

UN CRPD — Article 242006

States Parties shall ensure an inclusive education system at all levels and lifelong learning. Persons with disabilities are not excluded from the general education system on the basis of disability, and children with disabilities are not excluded from free and compulsory primary education, or from secondary education, on the basis of disability.

Masking / Camouflaging

/ ˈmɑːskɪŋ / ˈkæməˌflɑːʒɪŋ /

noun · clinical psychology / autistic studies — relatively new clinical concept

Wikipedia / Clinical Literature2024

Masking (also camouflaging) is the process by which autistic people learn to conceal or suppress autistic traits in order to blend into neurotypical society. Strategies include suppressing stimming, forcing eye contact, mimicking neurotypical facial expressions, and scripting conversations. Research (Hull et al., 2017; 2019) links chronic masking to significantly elevated rates of anxiety, depression, burnout, and suicidal ideation. Autistic women and non-binary individuals are thought to mask more, partially explaining the male-skewed diagnosis ratio.

Clinical Research (Hull et al.)2019

Camouflaging is defined as the use of compensatory strategies to mask the challenges and assimilate into neurotypical society. Three primary components: assimilation (trying to fit in or not appear autistic), compensation (employing strategies to mask autistic difficulties), and masking (hiding autistic characteristics). Studies show camouflaging is associated with poorer mental health outcomes and delayed diagnosis, particularly in women and girls.

Neurodivergent / Neurotypical

/ ˌnjʊərəʊdaɪˈvɜːdʒənt / / ˌnjʊərəʊˈtɪpɪkəl /

adjective · coined by Kassiane Asasumasu (neurodivergent), c. 1990s

Cambridge Dictionary2024

Neurodivergent: having a brain that works differently from most people in how it processes information, develops, or behaves, for example a person with dyslexia, ADHD, or autism is neurodivergent. Neurotypical: having a brain that processes information in the way that is typical for most people. Often abbreviated NT.

WikipediaRetrieved 2025

The term "neurodivergent" was coined by Kassiane Asasumasu, an autistic activist, to describe people with any neurological variation — including autism, ADHD, dyslexia, and others. It is broader than "autistic" and inclusive of multiple conditions. "Neurotypical" was originally a term from autistic communities to describe non-autistic people, later extended to mean anyone whose neurological development and functioning follow typical patterns. Both terms reflect social-model rather than medical-model framing.

Section 02 — Epidemiology

Prevalence Data

How autism diagnosis rates have evolved — and why the increase is partly diagnostic, partly real, and entirely contested.

ASD Prevalence in U.S. Children (CDC ADDM)
Children aged 8 years — 2000 to 2022 · Rate per 1,000
Global ASD Estimates vs. U.S. Rates
U.S. CDC vs. WHO global estimates · per 1,000 children
ADHD Prevalence — U.S. Children (CDC)
Ages 3–17 ever diagnosed · % · 2003–2022
ASD by Demographic (2022 CDC Data)
Prevalence per 1,000 children aged 8 by race/ethnicity
Why are rates rising? Researchers cite four overlapping explanations: (1) broadened diagnostic criteria — DSM-5 (2013) collapsed Asperger's, PDD-NOS, and childhood disintegrative disorder into a single ASD spectrum; (2) increased awareness among clinicians, educators, and parents; (3) reduced stigma leading more families to seek diagnosis; and (4) possible genuine increase due to environmental factors (advanced parental age, prenatal exposures). Most researchers assign the majority of the observed increase to diagnostic and ascertainment factors, though the debate remains open and politically charged.
Section 03 — Etiology

Causes & Theories

The causal picture of autism is a multi-gene, multi-environment threshold model. No single cause explains all cases. This is settled science — but the politics around causes remain anything but settled.

Heritability & Genetic Contribution
Twin study estimates of ASD heritability
Confirmed Risk Factors
Evidence strength: HIGH / MODERATE / LOW
Genetic variants (combined)
HIGH
Advanced paternal age (>40)
HIGH
Advanced maternal age
HIGH
Prenatal valproate exposure
HIGH
Maternal rubella infection
MOD
Preterm birth / low birth weight
MOD
Prenatal pesticide exposure
MOD
Air pollution exposure
MOD
Vaccines (MMR, thimerosal)
NONE
The genetic architecture of autism is profoundly complex. An estimated 200–1,000 genes influence autism susceptibility. Some cases involve high-penetrance rare mutations (e.g., SHANK3, CNTNAP2, TSC1/2). Others involve polygenic risk — hundreds of common variants each contributing a tiny effect. Monogenic syndromes (Fragile X, Rett syndrome, Angelman syndrome) explain ~5–10% of ASD cases. Copy number variations (CNVs) explain another ~5–10%. The threshold model holds that genetic predisposition combines with environmental insults — probably during fetal brain development, before birth — to produce ASD. This means environment matters, but the window is prenatal, not postnatal vaccination.
Section 04 — Diagnostic Evolution

How Diagnosis Changed

The definition of autism has been revised dramatically since Kanner's 1943 description. Each revision expanded the spectrum and reframed what autism means.

1943
Kanner's "Infantile Autism"
Leo Kanner at Johns Hopkins describes 11 children with "extreme autistic aloneness" and "insistence on sameness." Narrow, severe definition. Wrongly blamed on "refrigerator mothers."
1944
Asperger's Paper
Hans Asperger (Austria) independently describes "autistic psychopathy" — higher-functioning children with normal intelligence. Not widely known until Wing (1981) translates it.
1980
DSM-III
First formal DSM classification: "Infantile Autism." Replaced psychoanalytic "childhood schizophrenia." Strict criteria, severe cases only. "Refrigerator mother" theory abandoned.
1994
DSM-IV
Adds Asperger Disorder, PDD-NOS, Rett's, and Childhood Disintegrative Disorder under Pervasive Developmental Disorders. Massively broadens who qualifies. Diagnosis rates begin climbing rapidly.
2013
DSM-5
Revolutionary consolidation: all PDDs collapsed into single "Autism Spectrum Disorder" (ASD). Eliminates Asperger's as a separate diagnosis. Adds severity levels (1/2/3). Causes significant controversy in autistic community.
2022
DSM-5-TR
Text revision clarifies sensory criteria, adds "social (pragmatic) communication disorder" as a separate diagnosis for those who no longer meet ASD criteria. Minor updates to reflect current research.
1943–1944
History
Kanner & Asperger independently describe autism
Leo Kanner's "Autistic Disturbances of Affective Contact" and Hans Asperger's "Autistic Psychopathy in Childhood" are published, but in different countries, different languages, and different contexts. Kanner's severe profile dominates for decades.
1950s–1960s
Controversy
Bruno Bettelheim's "refrigerator mother" theory
Psychiatrist Bruno Bettelheim falsely claimed autism was caused by emotionally cold, "refrigerator" mothers. This caused enormous, lasting harm to families. Bettelheim was later exposed as having fabricated credentials and abused children in his care.
1991–1993
Movement
Autism Network International founded; Jim Sinclair's "Don't Mourn for Us"
Jim Sinclair's 1993 speech at the International Conference on Autism became foundational for the neurodiversity movement: "Autism is a way of being. It is not possible to separate the person from the autism." ANI was the first autistic-run autism organization.
1998
Controversy
Wakefield's fraudulent vaccine-autism paper published in The Lancet
Andrew Wakefield published a paper in The Lancet claiming the MMR vaccine caused autism. The paper involved only 12 children, was funded by attorneys seeking to sue vaccine manufacturers, and involved ethical violations including invasive procedures on children. It was fully retracted in 2010. Wakefield lost his medical license. The anti-vaccine movement it spawned continues to cause measles outbreaks worldwide.
1998
Movement
Judy Singer coins "neurodiversity"; Harvey Blume writes in The Atlantic
Sociologist Judy Singer introduced "neurodiversity" in her sociology thesis. Harvey Blume used it in The Atlantic: "Neurodiversity may be every bit as crucial for the human race as biodiversity is for life in general." The attribution has since been contested — autistic community members on the InLv listserv claim the concept was developed collectively earlier.
2005
Politics
Autism Speaks founded by Bob and Suzanne Wright
Autism Speaks became the most prominent and best-funded autism organization in the U.S. It was almost immediately controversial within the autistic community for its cure-focused agenda, use of fear-based messaging, near-total exclusion of autistic people from its leadership and funding decisions, and later for funding the development of prenatal genetic screening.
2006
Movement
ASAN (Autistic Self Advocacy Network) founded by Ari Ne'eman
Founded to "Nothing About Us Without Us," ASAN became the leading autistic-run advocacy organization in the U.S. Its "Ransom Notes" campaign successfully pressured the NYU Child Study Center to remove stigmatizing advertisements. Ne'eman was later appointed to the National Council on Disability by President Obama.
2010
Controversy
Wakefield paper fully retracted; Wakefield struck off medical register
After an extensive investigation by journalist Brian Deer exposing ethical violations and data manipulation, The Lancet retracted the 1998 Wakefield paper in full. The UK's General Medical Council found Wakefield guilty of serious professional misconduct. Over 30 large-scale epidemiological studies had by this point found no link between vaccines and autism. Vaccination rates in many countries still have not recovered.
2013
DSM
DSM-5 eliminates Asperger syndrome as a separate diagnosis
The collapse of Asperger disorder, PDD-NOS, and childhood disintegrative disorder into "ASD" was clinically defensible but proved culturally explosive. Many "Aspies" had built identity around the Asperger diagnosis and felt it had been erased. Some people with DSM-IV Asperger's no longer met DSM-5 ASD criteria, raising concerns about lost access to services.
2025
Politics
RFK Jr. vows to "solve" autism by September; calls increased prevalence a "tragedy"
HHS Secretary Robert F. Kennedy Jr. held a press conference claiming an unidentified environmental toxin caused the rise in autism, pledging a September deadline to identify it. Autism researchers criticized the claims as scientifically baseless. Simultaneously, the Trump administration cut millions in autism research funding and eliminated autism from Department of Defense research programs, creating a striking contradiction. Autistic advocacy groups protested the framing of autism as a "tragedy."
Section 05 — Pharmacology

Medications & Treatments

There is no approved medication for autism itself — only medications that target co-occurring conditions (anxiety, ADHD, irritability, etc.). ADHD has a robust pharmacological evidence base.

Important distinction: No medication "treats" autism. FDA-approved medications for autistic individuals target specific symptoms: aripiprazole (Abilify) and risperidone (Risperdal) are FDA-approved specifically for irritability associated with autism in children. All other psychiatric medications used in autism are off-label. ADHD, which co-occurs in up to 50–70% of autistic people, has the most established pharmacological treatment.

ADHD Medications

Stimulants — Methylphenidate First-line — MPH Class
Ritalin / Ritalin LA
methylphenidate HCl (IR & ER)
MPH
Oldest, most studied. IR 4–6h, LA 8–10h. First-line for children. Generic available.
Concerta
methylphenidate HCl ER (OROS)
MPH
12-hour osmotic delivery. Widely used in schools. 22% immediate + 78% extended release.
Focalin / Focalin XR
dexmethylphenidate (d-isomer)
MPH
Pure d-isomer; twice as potent mg-for-mg as racemic MPH. XR delivers 10–12h.
Jornay PM
methylphenidate HCl ER (delayed)
MPH
Novel formulation: taken at bedtime, delayed release kicks in at wake-up. Targets morning symptoms.
Daytrana
methylphenidate transdermal patch
MPH
Patch applied to hip; can be removed to end effect. Useful for swallowing difficulties.
Cotempla XR-ODT
methylphenidate ER orally disintegrating
MPH
Dissolves on tongue. 8–10h duration. Approved for ages 6–17.
Stimulants — Amphetamine First-line — AMP Class
Adderall / Adderall XR
mixed amphetamine salts (4:1 d:l ratio)
AMP
Most prescribed brand in U.S. XR 8–12h. IR 4–6h. Combination of d- and l-amphetamine.
Vyvanse
lisdexamfetamine dimesylate (prodrug)
AMP
Prodrug converted to d-amphetamine in bloodstream. Lower abuse potential. 12–14h. FDA-approved adults + children + binge eating.
Dexedrine / ProCentra
d-amphetamine sulfate
AMP
Pure d-amphetamine. Older formulation. ER (Spansule) available. High efficacy, high abuse potential.
Mydayis
mixed amphetamine salts XR triple-bead
AMP
Triple-bead technology. Up to 16h duration. For adults and ages 13+. Useful for long work/school days.
Evekeo / Evekeo ODT
amphetamine sulfate (racemic, 50:50)
AMP
Racemic (equal d:l). Different profile from Adderall. Also FDA-approved for narcolepsy and obesity.
Dyanavel XR
amphetamine oral suspension ER
AMP
Liquid extended-release amphetamine. For those who cannot swallow pills. 13h duration.
Non-Stimulants — ADHD Second-line / Alternative
Strattera
atomoxetine HCl
NRI
Selective norepinephrine reuptake inhibitor. Only non-stimulant FDA-approved for adult ADHD. Onset 2–4 weeks. No abuse potential. Black box: suicidality warning in children/adolescents.
Qelbree
viloxazine extended-release
SNRI-like
Newest non-stimulant. FDA-approved 2021 (children) & 2022 (adults). Selective norepinephrine/serotonin modulator. Generally well-tolerated.
Intuniv
guanfacine ER
α2A agonist
Alpha-2A adrenergic agonist. FDA-approved ADHD ages 6–17. Often combined with stimulants. Also reduces aggression and tic severity. Sedating, lowers BP.
Kapvay / Onyda XR
clonidine ER
α2 agonist
Alpha-2 adrenergic agonist. FDA-approved ADHD ages 6–17. Can help with sleep onset. Also used for tics. More sedating than guanfacine.
Wellbutrin
bupropion HCl (off-label)
NDRI
Norepinephrine-dopamine reuptake inhibitor. Off-label for ADHD. Often used when comorbid depression present. Lowers seizure threshold.
FDA-Approved for Autism Symptoms Irritability & Co-occurring Conditions
Abilify
aripiprazole
Atypical AP
FDA-approved for irritability associated with autism (ages 6–17). Partial D2 agonist. Weight gain risk. Available as liquid, tablet, injection.
Risperdal
risperidone
Atypical AP
FDA-approved for irritability associated with autism (ages 5–16). D2/5-HT2A antagonist. Significant weight gain and metabolic effects. Widely used, long track record.
Zoloft / Prozac / Lexapro
sertraline / fluoxetine / escitalopram
SSRI
Off-label for anxiety, OCD, depression in autism. Often first-line for anxiety. Autistic individuals may be more sensitive to activating side effects; start low.
Melatonin (supplement)
melatonin 0.5–10 mg
Supplement
Sleep onset insomnia affects 40–80% of autistic individuals. Melatonin is the most widely used and evidence-supported intervention. Prolonged-release melatonin (Circadin) approved in EU for autism-related insomnia in children.
Catapres / Tenex
clonidine / guanfacine IR (off-label)
α2 agonist
Off-label for aggression, hyperarousal, and sleep in autism. Used at low doses. Often useful when co-occurring ADHD + anxiety present.
Stimulant efficacy in ADHD: Meta-analyses show that ~80% of children with ADHD respond to stimulant medication when the correct drug and dose are found. Effect sizes are among the largest of any psychiatric medication (Cohen's d ≈ 0.9–1.0 for core symptoms). However, stimulants are Schedule II controlled substances, carry real cardiovascular risks, suppress appetite, and can exacerbate anxiety. Response rates in autistic individuals with ADHD tend to be lower (~60%) and side effects more pronounced. Non-stimulants are often preferable in this population.
Section 06 — Co-occurring Conditions

Co-morbidities & Overlap

Autism rarely occurs in isolation. The prevalence of co-occurring conditions is extraordinarily high — so high that "pure" autism without any co-occurring condition is statistically the exception.

ADHD co-occurring
Up to 70%
Anxiety disorders
40–82%
Sleep disorders
40–80%
Depression
23–37%
Epilepsy / Seizures
8–30%
Intellectual disability
26.7%
GI problems
~50%
OCD
11–37%
Sensory processing differences
~90%
Suicidality (lifetime)
28–66%

Sources: Bougeard et al. (2024), FOCUS; DSM-5-TR; CDC ADDM 2022 data. Ranges reflect heterogeneity across studies and populations.

Section 07 — Contested Terrain

The Controversies

Neurodiversity and autism are among the most politically and scientifically contested territories in contemporary medicine. These are not manufactured controversies — they reflect genuine, unresolved tensions about identity, power, medicine, and science.

1
The Vaccine–Autism Myth
Scientifically Resolved

The claim: In 1998, Andrew Wakefield published a Lancet paper claiming the MMR vaccine caused autism in 12 children. The paper triggered a global panic that persists to this day.

The reality: The paper was based on 12 children — statistically meaningless. It was funded by attorneys preparing to sue vaccine manufacturers (Wakefield received £435,643). Investigative journalist Brian Deer uncovered that Wakefield had manipulated data. The paper was fully retracted by The Lancet in 2010. Wakefield was struck off the British medical register. Fourteen separate studies involving hundreds of thousands of children found no link between vaccines and autism. The scientific question is closed.

The ongoing damage: Despite scientific resolution, the myth has not died. Measles, largely eliminated in many countries, returned as vaccination rates fell. As of 2025, Robert F. Kennedy Jr. — who built a significant career promoting vaccine skepticism — became U.S. Secretary of Health and Human Services. The anti-vaccine movement he has amplified continues to influence public health policy.

Scientific Consensus
Vaccines do not cause autism. Over 30 large-scale studies involving millions of children in multiple countries confirm this. Autism begins in utero — brain differences are detectable prenatally, before any vaccines are administered.
The Harm
The myth has caused measles outbreaks, pertussis resurgence, deaths of unvaccinated children, massive anxiety among parents, and has misdirected decades of research funding away from productive lines of inquiry. It has also caused real harm to autistic people by framing autism as something to be prevented at all costs.
2
ABA Therapy: Treatment or Trauma?
Intensely Active

Applied Behavior Analysis (ABA) is the most widely used and most heavily funded autism intervention in the United States, often mandated by insurance and recommended by pediatricians. It is based on behaviorist principles: reinforcing desired behaviors and extinguishing undesired ones.

Origins and history: ABA was developed in the 1960s by Ivar Lovaas, who explicitly sought to make autistic children "indistinguishable from their peers." Early ABA used aversive techniques including electric shocks (still used at the Judge Rotenberg Center until the FDA banned it in 2020, then unbanned under the Trump administration in 2025).

Supporters Argue
Modern ABA is naturalistic, play-based, and child-led. It can teach communication, self-care, and academic skills. It is the only autism intervention with federal support for evidence base. When implemented correctly, it does not attempt to eliminate benign autistic traits. Approximately 60–70% of children who receive intensive early ABA no longer meet diagnostic criteria for ASD.
Critics Argue (Many Autistic Adults)
ABA teaches autistic people that their natural way of being is wrong. Even modern ABA often targets stimming and eye contact — behaviors that are harmless or serve regulatory functions. A 2020 survey found the overwhelming majority of autistic adults who received ABA as children described it as harmful and traumatizing. PTSD rates are elevated in ABA recipients. The "success" metric — appearing neurotypical — is itself problematic. The evidence base is thin and riddled with conflicts of interest.

Methodological problems: A 2020 meta-analysis (Project AIM) reviewed 150 studies of ABA published 1970–2018 and found serious methodological problems: 70% had undisclosed conflicts of interest, only 11 included any mention of adverse events, and evidence for efficacy largely disappeared when limited to randomized controlled trials without detection bias.

3
Medical Model vs. Social Model vs. Neurodiversity Paradigm
Philosophical

This is the foundational ideological battleground of the entire field. Three incompatible frameworks exist simultaneously:

Medical Model
Autism is a disorder — a set of deficits in the individual that cause suffering and functional impairment. Treatment should aim to remediate those deficits. Parents who want their child to function more independently and access more opportunities are acting in the child's interest. Cure research is ethical and important.
Social Model (strong version)
Disability is created by societal barriers, not individual impairment. If society were designed for neurodiverse people, autism would not be disabling. The problem is inaccessible environments and social prejudice. "Cure" is ethnocide — the elimination of a minority group's identity.

The neurodiversity paradigm (Judy Singer, Ari Ne'eman, Nick Walker) attempts a middle position: cognitive variation is natural human biodiversity. Not all autistic characteristics require treatment, but specific harmful traits (seizures, self-injury) can be medically addressed. Accommodation, not normalization, is the goal.

The core tension is sharpest around profoundly autistic individuals — nonspeaking adults, people who cannot live independently, people in acute distress — whose needs may be fundamentally different from those of the high-functioning adults who dominate online neurodiversity discourse. Critics argue the neurodiversity movement effectively represents only the highest-functioning end of the spectrum while claiming to speak for all.

4
Is the Prevalence Increase Real?
Research Debate

ASD prevalence in the U.S. has risen from 1 in 150 (2000) to 1 in 31 (2025) — a 312% increase in 25 years. This is either: (a) one of the fastest-rising genuine epidemics in modern history, or (b) an artifact of broadened diagnosis, increased awareness, and changed detection practices. Or some combination of both.

Primarily Diagnostic / Ascertainment
DSM-IV (1994) significantly broadened criteria. DSM-5 broadened further. Awareness dramatically increased. Previously undiagnosed adults are now being identified. Healthcare inequities mean minority children were historically underdiagnosed and are now being identified at higher rates — CDC 2022 data show autism prevalence is now higher in Black and Hispanic children than white children, reversing historical patterns.
Genuine Increase Possible
Advanced paternal age has increased. Environmental exposures (endocrine disruptors, pesticides, air pollution) have increased. Preterm birth survival has increased (preterm birth is an ASD risk factor). The magnitude of the increase — even after accounting for diagnostic expansion — is too large to explain purely by ascertainment. A genuine increase of perhaps 30–50% above the historical baseline is plausible to many researchers.

RFK Jr.'s framing of the increase as a "pharmaceutical-era epidemic" caused by environmental toxins (specifically, the vaccine-adjacent framing) is not supported by evidence. The rise predates the vaccine schedule changes he cites and closely tracks diagnostic broadening milestones.

5
The Underdiagnosis of Women & Girls
Growing Recognition

The 4:1 male-to-female diagnostic ratio is almost certainly an artifact of bias, not biology. Multiple lines of evidence suggest the "true" sex ratio is closer to 2:1 or 3:1.

Why women are underdiagnosed: Autistic women and girls tend to engage in higher levels of masking/camouflaging, having observed and mimicked social behavior more effectively. Many present differently from the male-typical phenotype used to construct diagnostic criteria (which were originally developed primarily on male samples). Clinicians consistently underestimate autism in female patients even when shown identical vignettes with only sex changed.

Consequences: Women reach diagnosis an average of 5–7 years later than men, typically in adulthood after burnout, after seeking help for anxiety or depression, or after their child is diagnosed. Chronic masking and delayed diagnosis are strongly associated with significantly worse mental health outcomes — including extraordinarily high rates of suicidal ideation in autistic women. Research consistently finds autistic women have the highest suicide risk of any demographic studied in autism research.

6
Who Coined "Neurodiversity"? (The Judy Singer Dispute)
Ongoing

Judy Singer, an Australian sociologist (who is herself autistic), has long been credited as the "mother of neurodiversity" for introducing the term in her 1998 sociology thesis and a subsequent book chapter. Harvey Blume popularized it in The Atlantic the same year.

In 2024, a group of autistic academics published a letter in the journal Autism arguing this credit is misplaced. They assert the concept and term emerged collectively from the InLv (Independent Living on the autistic Spectrum) email listserv — a community Singer was part of and drew on with members' consent, but did not originate.

The controversy intensified after Singer made comments on social media in 2023 using derogatory language about transgender people, leading many neurodiversity advocates to distance themselves from her and re-examine the founding narrative. Singer's contested attribution has become entangled with ideological disputes about whether neurodiversity advocacy should extend to other marginalized groups.

7
The Asperger Erasure: DSM-5 and Identity
Identity & Policy

The DSM-5's 2013 collapse of Asperger syndrome into ASD was clinically defensible — research showed no reliable distinction in neurobiology or genetics between Asperger's and high-functioning autism. But the social and political consequences were significant.

Many people had built strong identities around the "Aspie" label. Autistic culture, communities, and even humor had developed around it. The diagnosis was eliminated at the stroke of a pen. Some people who had been diagnosed with Asperger's under DSM-IV no longer met DSM-5 ASD criteria — risking loss of services, legal protections, and accommodations.

Additionally, the Asperger erasure raised the problem of Hans Asperger's wartime record. Historian Herwig Czech's 2018 research documented that Asperger had cooperated with the Nazi regime and referred children to Am Spiegelgrund — a clinic where disabled children were killed as part of the Action T4 euthanasia program. Whether Asperger was a collaborator, an opportunist, or a man trying to protect some children under extreme conditions remains genuinely contested among historians.

8
ADHD: Real Disorder or Overdiagnosis?
Highly Politicized

ADHD is the most diagnosed neurodevelopmental condition in the world and the most contested. It sits at the intersection of pharmaceutical interests, educational pressures, cultural attitudes toward behavior, and genuine neurological variation.

ADHD Is Real and Undertreated
ADHD has the highest heritability of any psychiatric condition (~70–80%). Neuroimaging consistently shows structural and functional differences in ADHD brains — smaller prefrontal cortex, reduced dopamine signaling. Stimulant medications produce among the largest effect sizes in psychiatry. Untreated ADHD is associated with academic failure, higher unemployment, relationship difficulties, accidents, addiction, and incarceration. ADHD in girls and adults is significantly undertreated.
Legitimate Concerns
The youngest children in a school year are significantly more likely to be diagnosed with ADHD than the oldest — "relative age effect" is one of the most replicated findings in education research, suggesting some diagnoses reflect developmental immaturity, not disorder. U.S. ADHD diagnosis rates (9–11% of children) are 2–3x higher than European rates. Direct-to-consumer pharmaceutical advertising is prohibited in most countries but legal in the U.S. Stimulants are among the most diverted controlled substances on college campuses. Some critics argue ADHD pathologizes normal variation in attention that is poorly suited to industrial-era schooling.
Section 08 — Politics & Policy

The Political Landscape

Autism and neurodiversity have become deeply politicized — entangled with vaccine politics, disability rights, educational policy, and federal funding battles.

RFK Jr. & the Trump Administration (2025)

Robert F. Kennedy Jr., appointed Secretary of Health and Human Services in January 2025, made autism a centerpiece of his early tenure. He held press conferences claiming an environmental toxin was responsible for the autism "epidemic" and pledged to identify the cause by September 2025.

The contradiction was stark: simultaneously, the Trump administration cut millions in autism research funding, eliminated autism from Department of Defense Congressionally Directed Medical Research Programs, and NIH shifts ended or delayed multiple ongoing autism studies. ProPublica reported in August 2025 that Kennedy had eliminated parts of HHS actively investigating autism causes while vowing to find them.

Research Impact
Autism research funding cuts are occurring in the same administration that has put autism at the center of public health messaging — a contradiction that researchers and advocates have called "catastrophic." Kennedy also disputed CDC prevalence data at a press conference without scientific evidence, characterizing the increase as an "epidemic" caused by unnamed environmental toxins.

Autism Speaks vs. Autistic Self-Advocacy

The tension between parent-led and autistic-led advocacy organizations represents one of the deepest political fault lines in the field. Autism Speaks, the largest autism charity by revenue, has historically devoted the majority of its research budget to genetic and biomedical research, including prenatal genetic screening, which many autistic people view as eugenics by another name.

ASAN, the Autistic Self Advocacy Network, has led the "Nothing About Us Without Us" movement and consistently opposed cure-focused research agendas. The organization's founding principle — that autistic people must be central to decisions about autism — directly challenges the Autism Speaks model in which parents and professionals set the agenda.

A 2015 letter signed by 33 disability organizations to major U.S. foundations and funders called for divestment from Autism Speaks due to its history of excluding autistic voices and spreading fear-based narratives.

IDEA, ADA & Legal Rights

In the United States, autistic people's rights are protected by a patchwork of federal law. The Individuals with Disabilities Education Act (IDEA) entitles children with disabilities to "free appropriate public education" in the "least restrictive environment." The Americans with Disabilities Act (ADA) prohibits discrimination in employment, public accommodations, and services.

In practice, access to services remains deeply unequal by race, income, and geography. ABA therapy insurance mandates in most states have made it the default intervention despite contested evidence. Transition services for autistic adults are chronically underfunded — the vast majority of autistic adults are unemployed or underemployed, and housing options are severely limited.

International Policy: CRPD & Inclusive Education

The UN Convention on the Rights of Persons with Disabilities (CRPD, 2006) frames disability through a human rights lens and has been ratified by 186 countries. The United States has signed but not ratified the CRPD — one of only two UN member states (along with Somalia) to have failed to do so.

Article 24 of the CRPD mandates inclusive education. Globally, implementation is inconsistent. Many high-income countries maintain parallel special education systems. The 2024 UNESCO Global Education Monitoring Report found that only a minority of countries have fully inclusive education systems, and that the gap between policy and practice remains vast.

Section 09 — Key Organizations

Major Organizations

Understanding who funds research, sets policy agendas, and shapes public narratives is essential to understanding the politics of neurodiversity.

Autism Speaks
Founded 2005 · U.S. · ~$80M annual revenue
Largest autism charity by budget. Historically cure-focused and parent-led. Significant improvements in autistic board representation in recent years. Funds genetic research and funds insurance advocacy. Remains controversial in autistic community for past fear-based messaging and prenatal screening research.
Mixed/Contested
ASAN — Autistic Self Advocacy Network
Founded 2006 · U.S. · Autistic-led
The leading autistic-run U.S. advocacy organization. Opposes cure research and ABA mandates. Runs the "Nothing About Us Without Us" framework. Policy work on employment, housing, education. Closely aligned with disability rights movement.
Neurodiversity
Autism Science Foundation
Founded 2009 · U.S. · Science-focused
Founded by former Autism Speaks staff who disagreed with vaccine-related funding. Firmly pro-vaccine, evidence-based. Funds biomedical research. Neither strongly cure-focused nor neurodiversity movement-aligned. Scientifically mainstream.
Science-Based
INSAR — Intl. Society for Autism Research
Founded 2001 · International · Academic
The main academic professional society for autism researchers. Annual meeting is the largest gathering of autism scientists globally. Increasingly incorporates community-based participatory research and autistic researcher participation. Publishes Autism Research journal.
Academic
Autism Research Institute (ARI)
Founded 1967 · U.S. · Bernard Rimland
One of the oldest autism research organizations. Founded by Bernard Rimland, who helped disprove the refrigerator mother theory. Has history of promoting biomedical and dietary interventions with variable evidence bases. More cure-oriented than neurodiversity-aligned.
Biomedical Focus
National Council on Severe Autism (NCSA)
Founded 2018 · U.S. · Parent-led
Represents families of profoundly autistic individuals. Explicitly critical of neurodiversity movement, arguing it marginalizes those with highest support needs. Advocates for residential facilities, intensive interventions, and medical research. Significant tension with ASAN.
Medical Model
CHADD — Children & Adults with ADHD
Founded 1987 · U.S.
The leading ADHD advocacy and information organization in the U.S. Generally aligned with mainstream psychiatry and supports medication treatment. Has received pharmaceutical industry funding, which critics note as a potential conflict of interest. Provides extensive educational resources.
Medical/Support
EUCAP — European Council of Autistic People
Founded 2021 · Europe · Autistic-led
Pan-European autistic-led organization. In 2024 published a position statement calling ABA harmful and counterproductive based on surveys of autistic people. Advocates for autistic inclusion in EU policy. Aligned with neurodiversity paradigm and CRPD rights framework.
Neurodiversity